세계의 소화기 관련 제품 시장 : 디바이스별, 질환별, 최종 사용자별 예측(-2029년)

Gastrointestinal Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), (Gastrointestinal cancer), End-User (Hospitals, ASC) - Forecast to 2029

US $ 4,950 ￦ 6,901,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,272,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,363,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,943,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 소화기 관련 제품 시장 규모는 2024년 147억 달러에서 2029년까지 197억 달러에 이를 것으로 평가되고, 예측 기간 동안 복합 연간 성장률(CAGR) 6.1%의 성장이 전망됩니다.

시장은 소화기 질환의 이환율 증가, 기술 향상, 고령화, 의료비 상승, 인지도 향상 및 스크리닝 노력, 연구 개발비 증가, 맞춤형 의료 필요성, 신흥 시장 경제 적 확대 등의 요인에 의해 견인되고 있습니다. 소화기 관련 제품 산업은 이러한 요인의 복합적인 영향으로 역동적이고 진화하고 있습니다.

조사 범위
조사 대상년도	2021년-2029년
기준년	2023년
예측 기간	2024년-2029년
단위	10억 달러
부문	디바이스별, 질병별, 최종 사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

"디바이스별로 내시경 부문은 예측 기간에 가장 큰 점유율을 차지합니다."

내시경 기술은 폴립 절제, 조직 생검, 스텐트 유치, 종양 절제 등의 치료 및 진단을 가능하게 합니다. 이러한 개발은 다양한 소화기 질환에 대한 내시경 검사의 이용을 증가시키고 있습니다.

"질환별로 GERD 부문은 예측 기간에 가장 큰 점유율을 차지합니다."

라이프스타일 요인, 비만, 고령화, 진단/치료 옵션의 충실 등에 의한 GERD 유병률 증가가 소화기 내과 시장 점유율을 크게 밀어 올리고 있습니다. 인지도 향상과 기술 진보가 계속됨에 따라 소화기 관련 제품 서비스에 대한 수요가 증가하고 시장 성장을 더욱 촉진할 것으로 예상됩니다. 세계의적인 노화에 따라 GERD의 이환율이 증가하고 있습니다. 고령자는 식도 운동과 하부 식도 괄약근의 기능이 변화하기 때문에 GERD에 걸리기 쉬워집니다.

"아시아태평양이 예측 기간에 가장 높은 복합 연간 성장률(CAGR)을 나타낼 것으로 추정됩니다."

일본, 한국, 중국을 포함한 많은 아시아태평양 국가에서는 고령화에 따라 인구 동태가 변화하고 있습니다. 노인은 GERD와 같은 질병의 유병률이 높고 복잡한 의료 요구가 있습니다.

이 보고서는 세계의 소화기 관련 제품 시장에 대한 조사 분석을 통해 주요 촉진요인과 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

• 소화기 관련 제품 시장 개요
• 아시아태평양 소화기 관련 제품 시장 : 디바이스별, 지역별(2023년)
• 소화기 관련 제품 시장의 지리적 스냅샷

제5장 시장 개요

• 소개
• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
  • 과제
• 산업 동향
• 기술 분석
  • 주요 기술
  • 보완 기술
  • 인접 기술
• 밸류체인 분석
• Porter's Five Forces 분석
• 규제 상황
  • 규제 분석
  • 규제기관, 정부기관, 기타 조직
• 특허 분석
• 무역 분석
  • HS코드 : 소화기용 기구
  • 수입 데이터
  • 수출 데이터
• 가격 분석
• 상환 분석
• 주된 회의와 이벤트(2024년-2025년)
• 주요 이해관계자와 구매 기준
• 언멧 요구 요구의 분석
• 최종 사용자의 기대
• 생태계 분석
• 사례 연구 분석
• 공급망 분석
• 투자와 자금조달 시나리오
• 소화기 관련 제품 시장에 대한 생성형 AI/AI의 영향

제6장 소화기 관련 제품 시장 : 디바이스별

• 소개
• 내시경 디바이스
  • 유연한 내시경
  • 경성 내시경
  • 캡슐 내시경
  • 기타 내시경 디바이스
• 어블레이션 디바이스
  • 고주파 어블레이션 디바이스
  • 마이크로파 어블레이션 디바이스
  • 냉동 절제 장치
  • 레이저 어블레이션 디바이스
  • 기타 어블레이션 디바이스
• 운동 검사 장치
  • 식도 내압 측정 장치
  • 24시간 PH 임피던스 검사 장치
  • 항문 직장 내압 측정 장치
  • 기타 운동 검사 장치
• 생검 디바이스
  • 바늘 생검 기기
  • 기타 생검 기기
• 스텐트 디바이스
  • 담관 스텐트
  • 결장 스텐트
  • 십이지장 스텐트
  • 췌장 스텐트
  • 식도 스텐트
• PH 모니터링 장치
  • 식도 PH 모니터링 카테터
  • 무선 PH 모니터링 캡슐
  • 휴대용 PH 모니터링 시스템
• 기타 소화기 관련 디바이스
  • 위내 풍선
  • 소화기용 튜브
  • 치질 치료 장치

제7장 소화기 관련 제품 시장 : 질환별

• 소개
• 소화기 암
• 위식도 역류증
• 과민성 장 증후군(IBS)
• 염증성 장질환(IBD)
• 기타 질환

제8장 소화기 관련 제품 시장 : 최종 사용자별

• 소개
• 병원
• 외래수술센터(ASC),독립계 수술센터
• 진료소
• 기타 최종 사용자

제9장 소화기 관련 제품 시장 :지역별

• 소개
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시 경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 아시아태평양의 거시 경제 전망
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 라틴아메리카의 거시 경제 전망
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 중동 및 아프리카의 거시 경제 전망
  • GCC 국가
  • 기타 중동?아프리카

제10장 경쟁 구도

• 개요
• 주요 기업의 전략/유력 기업
• 수익 분석(2021년-2023년)
• 시장 점유율 분석(2023년)
• 기업 평가 매트릭스: 주요 기업(2023년)
• 기업의 평가 매트릭스: 스타트업/중소기업(2023년)
• 경쟁 시나리오
• 브랜드/제품 비교
• 기업 평가 및 재무 지표
  • 재무지표
  • 기업의 평가

제11장 기업 프로파일

• 주요 기업
  • OLYMPUS CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • MEDTRONIC PLC
  • STRYKER CORPORATION
  • COOK MEDICAL
  • FUJIFILM CORPORATION
  • CONMED CORPORATION
  • ETHICON(A JOHNSON & JOHNSON SUBSIDIARY)
  • MERIT MEDICAL SYSTEMS
  • STERIS PLC
  • KARL STORZ SE & CO. KG
• 기타 기업
  • SHAILI ENDOSCOPY
  • TAEWOONG MEDICAL CO., LTD.
  • HOBBS MEDICAL, INC.
  • PENTAX MEDICAL
  • ERBE ELEKTROMEDIZIN
  • AMBU A/S
  • CAPSOVISION, INC.
  • INTROMEDIC, INC.
  • VIMEX ENDOSCOPY
  • TRIVITRON HEALTHCARE
  • MEDI-GLOBE CORPORATION
  • SONOSCAPE MEDICAL CORP.
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
  • MEDSPIRA

제12장 부록

BJH

영문 목차

영문목차

The global Gastroenterology/Gastrointestinal Products Market is projected to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of 6.1% from 2024 to 2029. The market for gastroenterology and gastrointestinal products is driven by several factors, such as the growing incidence of GI disorders, improvements in technology, aging populations, rising healthcare costs, increased awareness and screening initiatives, rising R&D spending, the need for personalized medicine, and economic expansion in emerging markets. The GI product industry is dynamic and ever-evolving due to the combined influence of these drivers.

Scope of the Report
Years Considered for the Study	2021-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Billion)
Segments	By Device, Disease, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"The endoscopy segment from the devices segment accounted for the largest share during the forecast period."

The Gastroenterology/Gastrointestinal product market is divided into Endoscopy, Ablations systems, Motility testing, Stenting devices, Ph monitoring, and other devices. The endoscopy segment accounted for the largest share during the forecast period. Endoscopic techniques enable the removal of polyps, tissue biopsies, stent implantation, and tumor ablation, among other therapeutic and diagnostic treatments. These developments support endoscopy's increasing use for a range of gastrointestinal disorders.

"The GERD segment in the diseases segment accounted for the largest share during the forecast period.."

The increasing prevalence of GERD, driven by lifestyle factors, obesity, aging populations, and enhanced diagnostic and treatment options, is significantly boosting the share of the gastroenterology market. As awareness grows and technological advancements continue, the demand for gastroenterological products and services is expected to rise, further driving market growth. As the global population ages, the incidence of GERD increases. Older adults are more susceptible to GERD due to changes in esophageal motility and the function of the lower esophageal sphincter.

"APAC is estimated to register the highest CAGR during the forecast period."

The Gastroenterology/Gastrointestinal Products Market is divided into Five regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Asia Pacific is witnessed to have the highest CAGR during the forecast period.. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. Older persons have a higher prevalence of diseases like GERD and complex healthcare needs.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW(16%)

List of Companies Profiled in the Report

• BOSTON SCIENTIFIC (U.S)
• MEDTRONIC (U.S)
• OLYMPUS CORPORATION (JAPAN)
• STRYKER (U.S.)
• GLOBUS MEDICAL (U.S.)
• COOK MEDICAL (US)
• ETHICON (SUBSIDIARY OF J&J)
• FUJIFILM (JAPAN)
• CONMED CORPORATION (US)
• KARL STORZ (GERMANY)

Research Coverage

This report studies the Gastroenterology/Gastrointestinal Products Market based on devices, diseases, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Gastroenterology/Gastrointestinal Products Market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (increasing GI diseases, technological advancements) , restraints (Cost of the system), challenges(regulatory policies), and opportunities (Increase in the minimally invasive procedures) contributing to the growth of the Gastroenterology/Gastrointestinal Products Market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Gastroenterology/Gastrointestinal Products Market.
• Market Development: Comprehensive information on the lucrative emerging markets by devices, diseases, end-users and region.
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Gastroenterology/Gastrointestinal Products Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Gastroenterology/Gastrointestinal Products Market..

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET RANKING ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE AND REGION (2023)
• 4.3 GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of GI disorders
    • 5.2.1.2 Technological advancements in gastroenterology products
    • 5.2.1.3 Growing aging population
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Stringent regulatory policies for GI products
    • 5.2.2.2 Increasing healthcare costs
    • 5.2.2.3 Unfavorable healthcare reforms in US
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing preference for minimally invasive surgery
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Changing regulatory landscape
    • 5.2.4.2 Shortage of trained physicians and endoscopists
• 5.3 INDUSTRY TRENDS
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Capsule endoscopy
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Laboratory testing
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Robotic surgery systems
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 PORTER'S FIVE FORCE ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 THREAT OF SUBSTITUTES
  • 5.6.3 BARGAINING POWER OF SUPPLIERS
  • 5.6.4 BARGAINING POWER OF BUYERS
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 REGULATORY LANDSCAPE
  • 5.7.1 REGULATORY ANALYSIS
    • 5.7.1.1 North America
      • 5.7.1.1.1 US
      • 5.7.1.1.2 Canada
    • 5.7.1.2 Europe
    • 5.7.1.3 Asia Pacific
      • 5.7.1.3.1 Japan
      • 5.7.1.3.2 China
  • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.8 PATENT ANALYSIS
  • 5.8.1 PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
  • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.9 TRADE ANALYSIS
  • 5.9.1 HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
  • 5.9.2 IMPORT DATA
  • 5.9.3 EXPORT DATA
• 5.10 PRICING ANALYSIS
• 5.11 REIMBURSEMENT ANALYSIS
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 UNMET NEEDS ANALYSIS
• 5.15 END-USER EXPECTATIONS
• 5.16 ECOSYSTEM ANALYSIS
• 5.17 CASE STUDY ANALYSIS
• 5.18 SUPPLY CHAIN ANALYSIS
• 5.19 INVESTMENT & FUNDING SCENARIO
• 5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

6 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE

• 6.1 INTRODUCTION
• 6.2 ENDOSCOPY DEVICES
  • 6.2.1 FLEXIBLE ENDOSCOPES
    • 6.2.1.1 Advantages such as flexibility and ease of use to drive demand for flexible endoscopes
  • 6.2.2 RIGID ENDOSCOPES
    • 6.2.2.1 Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth
  • 6.2.3 CAPSULE ENDOSCOPES
    • 6.2.3.1 Non-invasive nature of capsule endoscopes to drive adoption
  • 6.2.4 OTHER ENDOSCOPY DEVICES
• 6.3 ABLATION DEVICES
  • 6.3.1 RADIOFREQUENCY ABLATION DEVICES
    • 6.3.1.1 Low cost of radiofrequency ablation to contribute to market growth
  • 6.3.2 MICROWAVE ABLATION DEVICES
    • 6.3.2.1 Advantages over RF ablation to ensure sustained demand for microwave ablation devices
  • 6.3.3 CRYOABLATION DEVICES
    • 6.3.3.1 Increasing cancer incidence to drive market for cryoablation devices
  • 6.3.4 LASER ABLATION DEVICES
    • 6.3.4.1 High efficacy and safety to drive adoption of laser/light ablation devices
  • 6.3.5 OTHER ABLATION DEVICES
• 6.4 MOTILITY TESTING DEVICES
  • 6.4.1 ESOPHAGEAL MANOMETRY DEVICES
    • 6.4.1.1 Rising incidence of esophageal motility disorders to boost market growth
  • 6.4.2 4-HOUR PH IMPEDANCE TESTING DEVICES
    • 6.4.2.1 Ability to provide data useful for tailoring individualized treatment plans to favor market growth
  • 6.4.3 ANORECTAL MANOMETRY DEVICES
    • 6.4.3.1 Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth
  • 6.4.4 OTHER MOTILITY TESTING DEVICES
• 6.5 BIOPSY DEVICES
  • 6.5.1 NEEDLE BIOPSY DEVICES
    • 6.5.1.1 Increasing screening of gastrointestinal diseases to aid growth
  • 6.5.2 OTHER BIOPSY DEVICES
• 6.6 STENTING DEVICES
  • 6.6.1 BILIARY STENTS
    • 6.6.1.1 Increasing prevalence of bile duct cancer and chronic liver disease to drive growth
  • 6.6.2 COLONIC STENTS
    • 6.6.2.1 Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth
  • 6.6.3 DUODENAL STENTS
    • 6.6.3.1 Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents
  • 6.6.4 PANCREATIC STENTS
    • 6.6.4.1 Rising number of ERCP and PTC procedures to drive market growth
  • 6.6.5 ESOPHAGEAL STENTS
    • 6.6.5.1 Increasing incidence of esophageal cancer to propel market growth
• 6.7 PH MONITORING DEVICES
  • 6.7.1 ESOPHAGEAL PH MONITORING CATHETERS
    • 6.7.1.1 Growing sedentary lifestyles to drive demand
  • 6.7.2 WIRELESS PH MONITORING CAPSULES
    • 6.7.2.1 Reduced risk of open surgeries to boost market
  • 6.7.3 AMBULATORY PH MONITORING SYSTEMS
    • 6.7.3.1 Convenience and accuracy of ambulatory pH monitoring to drive market
• 6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES
  • 6.8.1 GASTRIC BALLOONS
    • 6.8.1.1 Minimally invasive nature of gastric balloons to boost adoption
  • 6.8.2 GASTROINTESTINAL TUBES
    • 6.8.2.1 Rising incidence of diseases to drive need for gastrointestinal tubes
  • 6.8.3 HEMORRHOID TREATMENT DEVICES
    • 6.8.3.1 Rising cases of hemorrhoids to support market growth

7 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE

• 7.1 INTRODUCTION
• 7.2 GASTROINTESTINAL CANCERS
  • 7.2.1 CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH
• 7.3 GASTROESOPHAGEAL REFLUX DISEASE
  • 7.3.1 GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH
• 7.4 IRRITABLE BOWEL SYNDROME (IBS)
  • 7.4.1 GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS
• 7.5 INFLAMMATORY BOWEL DISEASE (IBD)
  • 7.5.1 GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH
• 7.6 OTHER DISEASES

8 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS
• 8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS
  • 8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH
• 8.4 CLINICS
  • 8.4.1 GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET
• 8.5 OTHER END USERS

9 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American market during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 Increased availability of funding and presence of research institutes to propel market
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Favorable reimbursement scenario and increased geriatric population to aid market growth
  • 9.3.3 UK
    • 9.3.3.1 Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth
  • 9.3.4 FRANCE
    • 9.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
  • 9.3.5 ITALY
    • 9.3.5.1 High per capita income and improved healthcare system to drive market
  • 9.3.6 SPAIN
    • 9.3.6.1 Growing prevalence of cardiovascular diseases to boost market growth
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Favorable medical device reimbursement policies and public health insurance schemes to aid market growth
  • 9.4.3 CHINA
    • 9.4.3.1 Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing incidence of diseases like diabetes to enhance market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 High incidence of cancer to propel market growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increase in private healthcare investments and rise in medical tourism to aid market growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 10.3 REVENUE ANALYSIS, 2021-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Disease footprint
    • 10.5.5.3 End-user footprint
    • 10.5.5.4 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
• 10.7 COMPETITIVE SCENARIO
  • 10.7.1 PRODUCT LAUNCHES & APPROVALS
  • 10.7.2 DEALS
  • 10.7.3 EXPANSIONS
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPANY VALUATION & FINANCIAL METRICS
  • 10.9.1 FINANCIAL METRICS
  • 10.9.2 COMPANY VALUATION

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 OLYMPUS CORPORATION
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches & approvals
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 BOSTON SCIENTIFIC CORPORATION
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches & approvals
      • 11.1.2.3.2 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 MEDTRONIC PLC
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product approvals
      • 11.1.3.3.2 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 STRYKER CORPORATION
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product approvals
      • 11.1.4.3.2 Deals
      • 11.1.4.3.3 Expansions
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 COOK MEDICAL
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches & approvals
      • 11.1.5.3.2 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 FUJIFILM CORPORATION
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches & approvals
      • 11.1.6.3.2 Other developments
  • 11.1.7 CONMED CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches & approvals
  • 11.1.9 MERIT MEDICAL SYSTEMS
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches
  • 11.1.10 STERIS PLC
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 KARL STORZ SE & CO. KG
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Deals
• 11.2 OTHER PLAYERS
  • 11.2.1 SHAILI ENDOSCOPY
  • 11.2.2 TAEWOONG MEDICAL CO., LTD.
  • 11.2.3 HOBBS MEDICAL, INC.
  • 11.2.4 PENTAX MEDICAL
  • 11.2.5 ERBE ELEKTROMEDIZIN
  • 11.2.6 AMBU A/S
  • 11.2.7 CAPSOVISION, INC.
  • 11.2.8 INTROMEDIC, INC.
  • 11.2.9 VIMEX ENDOSCOPY
  • 11.2.10 TRIVITRON HEALTHCARE
  • 11.2.11 MEDI-GLOBE CORPORATION
  • 11.2.12 SONOSCAPE MEDICAL CORP.
  • 11.2.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
  • 11.2.14 MEDSPIRA

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료